glp 1 agonist medullary thyroid cancer GLP-1 medications and risk Thyroid cancer survivor wondering about
Description
66 Treatment with liraglutide substantially reduced the mean concentration of CRP in a retrospective study of obese individuals with T2DM, suggesting its potential as an anti-inflammatory drug
Exenatide alters myocardial glucose transport and uptake depending on insulin resistance and increases myocardial blood flow in patients with type 2 diabetes
Journal reference: Rodriguez, M
1 Excess adiposity is a major contributor to BP elevation, with estimates suggesting that obesity causes 65%-78% of primary hypertension cases
Coverage may expand, prescribing may standardize, and clinical frameworks may align
